Preliminary results show that after four weeks of regular IN therapy, functional skills improved, paving the way for a larger cohort study to assess the long-term safety and possible effectiveness of IN-insulin administration to treat and prevent functional decline in PD patients. This evidence concerns the gene INS and Parkinson disease.